Carnegie Investment Counsel’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $453K | Sell |
5,797
-624
| -10% | -$50.3K | 0.01% | 408 |
|
|
2026
Q1 | $556K | Buy |
6,421
+2,513
| +64% | +$241K | 0.01% | 394 |
|
|
2025
Q4 | $375K | Sell |
3,908
-170
| -4% | -$16.5K | 0.01% | 443 |
|
|
2025
Q3 | $388K | Buy |
4,078
+1,236
| +43% | +$114K | 0.01% | 431 |
|
|
2025
Q2 | $248K | Sell |
2,842
-17
| -0.6% | -$1.44K | 0.01% | 491 |
|
|
2025
Q1 | $239K | Buy |
2,859
+75
| +3% | +$6.71K | 0.01% | 460 |
|
|
2024
Q4 | $222K | Sell |
2,784
-955
| -26% | -$82.7K | 0.01% | 432 |
|
|
2024
Q3 | $337K | Sell |
3,739
-935
| -20% | -$78.7K | 0.01% | 389 |
|
|
2024
Q2 | $368K | Sell |
4,674
-10,511
| -69% | -$862K | 0.01% | 377 |
|
|
2024
Q1 | $1.32M | Sell |
15,185
-7,971
| -34% | -$680K | 0.04% | 258 |
|
|
2023
Q4 | $1.91M | Sell |
23,156
-4,842
| -17% | -$369K | 0.07% | 207 |
|
|
2023
Q3 | $2.19M | Sell |
27,998
-3,469
| -11% | -$290K | 0.08% | 196 |
|
|
2023
Q2 | $2.77M | Buy |
31,467
+762
| +2% | +$65.6K | 0.1% | 173 |
|
|
2023
Q1 | $2.48M | Buy |
30,705
+609
| +2% | +$49.6K | 0.1% | 181 |
|
|
2022
Q4 | $2.34M | Buy |
30,096
+2,797
| +10% | +$227K | 0.1% | 189 |
|
|
2022
Q3 | $2.2M | Buy |
27,299
+1,735
| +7% | +$156K | 0.11% | 186 |
|
|
2022
Q2 | $2.29M | Buy |
25,564
+408
| +2% | +$41.3K | 0.1% | 183 |
|
|
2022
Q1 | $2.79M | Buy |
25,156
+155
| +0.6% | +$16.4K | 0.1% | 181 |
|
|
2021
Q4 | $2.59M | Buy |
25,001
+17,054
| +215% | +$1.97M | 0.09% | 185 |
|
|
2021
Q3 | $997K | Hold |
7,947
| – | – | 0.04% | 245 |
|
|
2021
Q2 | $987K | Buy |
7,947
+157
| +2% | +$19.7K | 0.04% | 253 |
|
|
2021
Q1 | $922K | Buy |
7,790
+50
| +0.6% | +$5.86K | 0.04% | 252 |
|
|
2020
Q4 | $907K | Sell |
7,740
-896
| -10% | -$98.6K | 0.04% | 243 |
|
|
2020
Q3 | $897K | Buy |
8,636
+1,381
| +19% | +$139K | 0.05% | 223 |
|
|
2020
Q2 | $665K | Buy |
7,255
+89
| +1% | +$8.53K | 0.04% | 244 |
|
|
2020
Q1 | $647K | Sell |
7,166
-193
| -3% | -$20.5K | 0.05% | 239 |
|
|
2019
Q4 | $835K | Buy |
7,359
+868
| +13% | +$95.2K | 0.05% | 241 |
|
|
2019
Q3 | $705K | Buy |
6,491
+165
| +3% | +$17.2K | 0.05% | 247 |
|
|
2019
Q2 | $616K | Sell |
6,326
-1,125
| -15% | -$103K | 0.04% | 277 |
|
|
2019
Q1 | $679K | Hold |
7,451
| – | – | 0.05% | 256 |
|
|
2018
Q4 | $678K | Sell |
7,451
-7,882
| -51% | -$737K | 0.06% | 223 |
|
|
2018
Q3 | $1.43M | Buy |
15,333
+7,624
| +99% | +$705K | 0.12% | 171 |
|
|
2018
Q2 | $702K | Buy |
7,709
+1,640
| +27% | +$137K | 0.05% | 238 |
|
|
2018
Q1 | $519K | Sell |
6,069
-444
| -7% | -$36.6K | 0.04% | 246 |
|
|
2017
Q4 | $531K | Sell |
6,513
-4,425
| -40% | -$354K | 0.05% | 264 |
|
|
2017
Q3 | $864K | Sell |
10,938
-3,375
| -24% | -$280K | 0.1% | 190 |
|
|
2017
Q2 | $1.19M | Buy |
14,313
+4,366
| +44% | +$368K | 0.15% | 163 |
|
|
2017
Q1 | $825K | Sell |
9,947
-2,317
| -19% | -$181K | 0.1% | 190 |
|
|
2016
Q4 | $869K | Buy |
12,264
+1,050
| +9% | +$82.5K | 0.12% | 176 |
|
|
2016
Q3 | $926K | Buy |
11,214
+361
| +3% | +$31.5K | 0.13% | 165 |
|
|
2016
Q2 | $950K | Buy |
10,853
+268
| +3% | +$21.7K | 0.13% | 167 |
|
|
2016
Q1 | $793K | Sell |
10,585
-1,662
| -14% | -$125K | 0.12% | 176 |
|
|
2015
Q4 | $930K | Sell |
12,247
-301
| -2% | -$22.7K | 0.16% | 148 |
|
|
2015
Q3 | $913K | Buy |
12,548
+850
| +7% | +$62.6K | 0.16% | 149 |
|
|
2015
Q2 | $867K | Buy |
11,698
+1
| +0% | +$76 | 0.15% | 151 |
|
|
2015
Q1 | $911K | Buy |
11,697
+2,124
| +22% | +$161K | 0.16% | 141 |
|
|
2014
Q4 | $714K | Sell |
9,573
-1,129
| -11% | -$78.4K | 0.13% | 151 |
|
|
2014
Q3 | $663K | Buy |
10,702
+6,354
| +146% | +$404K | 0.13% | 160 |
|
|
2014
Q2 | $277K | Buy |
+4,348
| New | +$264K | 0.06% | 197 |
|
Other funds holding MDT
FWIA
GAM
SRIM
DC
Carnegie Investment Counsel's MDT Position: Q2 2026 in Review
Carnegie Investment Counsel reduced its Medtronic (MDT) stake by 9.7% in Q2 2026, selling an estimated $50.3K and leaving 5,797 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #408.
Carnegie Investment Counsel first reported a position in MDT in Q2 2014 and has held it in 49 quarters since. The position peaked at $2.79M in Q1 2022. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Carnegie Investment Counsel held 5,797 shares of Medtronic worth $453K as of Q2 2026.
- Carnegie Investment Counsel sold 624 Medtronic shares in Q2 2026, an estimated $50.3K.
- Medtronic made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #408 holding.
- Carnegie Investment Counsel first reported a position in Medtronic in Q2 2014 and has held it in 49 quarters since.
- Carnegie Investment Counsel's Medtronic position peaked at $2.79M in Q1 2022.
- 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.